Outcomes with durvalumab by tumour PD-L1 expression in unresectable, stage III non-small-cell lung cancer in the PACIFIC trial
- Resource Type
- Article
- Authors
- Paz-Ares, L.; Spira, A.; Raben, D.; Planchard, D.; Cho, B.C.; Özgüroğlu, M.; Daniel, D.; Villegas, A.; Vicente, D.; Hui, R.; Murakami, S.; Spigel, D.; Senan, S.; Langer, C.J.; Perez, B.A.; Boothman, A-M.; Broadhurst, H.; Wadsworth, C.; Dennis, P.A.; Antonia, S.J.; Faivre-Finn, C.
- Source
- In Annals of Oncology June 2020 31(6):798-806
- Subject
- Onco-Immunology
- Language
- ISSN
- 0923-7534